NASDAQ:STRZ

Starz Shares See Friday Jump With Margin Bets and Wall Street’s Mixed Calls

Starz Shares See Friday Jump With Margin Bets and Wall Street’s Mixed Calls

Starz shares closed at $22.27 Friday, up 2.58%, but ended the week down 3.7% after volatile trading. The company’s market value stood near $374 million as U.S. markets head into the Memorial Day break. Starz reported a first-quarter operating loss of $152.8 million on $306.9 million revenue after its split from Lionsgate. Analyst targets for the stock range widely, reflecting uncertainty over its streaming strategy and cash flow.
May 24, 2026

Stock Market Today

  • Genomic Test Could Spare Millions of Breast Cancer Patients Chemotherapy, Landmark Study Finds
    May 29, 2026, 8:16 PM EDT. A landmark study reveals that millions of breast cancer patients could safely skip chemotherapy thanks to the Prosigna genomic test, which analyses tumor genes to assess recurrence risk. The international OPTIMA trial, involving 4,429 patients, showed a 93.7% five-year cancer-free survival rate for those who avoided chemotherapy, nearly matching the 94.9% rate for those treated with it. Karen Bonham, a trial participant, described her relief upon learning she would not need chemotherapy, attributing her cancer-free status nine years post-diagnosis to the test's guidance. Experts hail the findings as gamechanging, potentially transforming breast cancer treatment by reducing unnecessary chemotherapy and its side effects, while maintaining patient safety.